That's a pretty big win for a company that most...
WD Highly Engage Send: EAC From 5/31/24
Jeff Siegel / Jun 4, 2024 BILLIONS Are Flowing Into This Psychedelics Firm AbbVie Stock got a lot of attention a couple weeks ago after the company made a major announcement. 
The American pharmaceutical giant recently announced an investment in Gilgamesh Pharmaceuticals. That deal put $65 million in Gilgamesh's pockets. It also gives the company the opportunity to make up to $1.95 billion in aggregate option fees and milestones, as well as tiered royalties. That's a pretty big win for a company that most folks never even heard of. But don't let its lack of attention from the investment community confuse you. Gilgamesh is a major player in the psychedelics medicine space. Its management team is a "who's who" of Big Pharma with connections to Pfizer (NYSE: PFE), Johnson & Johnson (NYSE: JNJ), Merck (NYSE: MRK), Biogen (NASDAQ: BIIB) and the NIH, just to name a few. Now, when most folks talk about psychedelics... >>> Read the full article here. Share on Twitter You signed up for our newsletter with the email indra21poetra@gmail.com.
You can manage your subscription and get our privacy policy here. This email is from Angel Publishing, 3 East Read Street, Baltimore, MD 21202
© Wealth Daily. | | | |
Tidak ada komentar:
Posting Komentar